医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Video of Mannatech’s Pure Aloe “Manapol Powder” Available on Business Wire’s Website

2017年04月07日 AM01:36
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

GUANGZHOU, China

A video is available on Business Wire’s Website featuring Mannatech®, Incorporated’s pure aloe product, Manapol® powder, the foundation of Mannatech’s nutritional supplement technology in China.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170406006024/en/

In this video, Mannatech’s CEO and President, Alfredo “Al” Bala, and Senior Global Wellness Director, Dr. Steve Nugent, talk about Mannatech’s Manapol powder as the purest and best source of aloe vera’s healthful properties. Manapol is a powerful element included in Mannatech’s Glyconutritional technology that is part of nearly all of its supplement products available in China through its cross-border e-commerce website, www.MeiTaiChina.com. † This includes its top selling product in China, Advanced Ambrotose®, which is fortified with Manapol and is clinically proven to boost the immune system, support digestive function and support cognitive function, including memory, mood and concentration.

Watch the video to learn more.

† Mannatech’s cross-border e-commerce model in China is a different opportunity from Mannatech’s MLM business in other markets. Customers who invite other customers to the Mannatech China cross-border e-commerce site gain rewards for future product purchases or cash redemption. The e-commerce business model is not multi-level marketing or direct selling.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170406006024/en/

CONTACT

Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245
pr@mannatech.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 新研究调查Masimo SpHb®在术后红细胞(RBC)输血最佳实践中的功用
  • 宝洁公司收购德国达姆施塔特默克集团的消费者健康业务
  • MOLOGEN AG: Collaboration with licensing partner ONCOLOGIE gains momentum
  • Vaxart Announces $5 Million Inavir® Revenue Milestone
  • 和铂医药与科伦博泰开展全球合作,共同开发多个创新全人源抗体药物